PeptideStack
5.2kquestions
20kanswers
220users

My lyophilised cake dissolved instantly — is that a bad sign?

Asked 10 Jun 2026Modified 8 days agoViewed 6k times
6

For context, I am working with a 10 mg presentation and a 2 mL fill.

I noticed this today and I have not touched anything since, in case the state is diagnostic.

I have not discarded anything yet, so a test is still possible if that is the recommendation.

Should I be treating this as a failure or as noise?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questions
lyophilisation
lyophilisation

Freeze-drying: primary and secondary drying, collapse temperature, the role of bulking agents and cryoprotectants such as mannitol and trehalose,…

17 questions
vial-inspection
vial-inspection

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after…

66 questions
shareeditfollowflag
NT
askedn_takahashi36k3810 Jun 2026

5 Answers

Sorted by votes
17

In practice, read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.

A 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.

Concentration and unit conversion at a glance

VialDiluentConcentration0.25 mg0.5 mg1 mg2.5 mg
5 mg1 mL5 mg/mL5 u10 u20 u50 u
5 mg2 mL2.5 mg/mL10 u20 u40 u100 u
10 mg1 mL10 mg/mL2.5 u5 u10 u25 u
10 mg2 mL5 mg/mL5 u10 u20 u50 u
10 mg3 mL3.33 mg/mL7.5 u15 u30 u75 u

Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.

It helps to be literal here: the order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.

The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.

Worth saying: if your arithmetic and someone else's disagree by a factor of ten, one of you has made a unit error.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

shareimprove this answerflag
P9
answeredplate_count_9k95k15811 Jul 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
11

Put another way, before anything else: a kitchen counter with an alcohol wipe is not an aseptic environment, and it is worth being honest about that rather than pretending the procedure is something it is not. What you are doing is reducing bioburden, not achieving sterility.

Check the barrel marking, not your memory of it.

Number of stopper piercings matters less than the gauge doing the piercing.

Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
LS
answeredlukas_sedlacek17k2712 Jul 2026
9

The part that matters: if the supplier documentation specifies a diluent, there is usually a reason, and if it specifies nothing, water for injection is the conservative default.

Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.

Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.

The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.

Do the arithmetic twice, ideally with someone else doing it independently.

edited 22 Jul 2026 by shear_at_the_front — added the method parameters

shareimprove this answerflag
SF
answeredshear_at_the_front15k2813 Jul 2026
7

Sodium chloride 0.9 per cent as a diluent is not a neutral substitution. Ionic strength affects peptide solubility and aggregation propensity.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.

The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

shareimprove this answerflag
AD
answeredanouk_desmet18k287 Jul 2026
7

This is not exotic. It is just the difference between doing it deliberately and doing it approximately.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.

I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
PM
answeredp_mkhize41k13815 Jul 2026
Note that the label instructions differ between agents on precisely this point. – seamus_brady 3 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.